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Abstract: Selenium (Se) is an essential trace element for several organisms and is present in proteins as selenocysteine 
(Sec or U), an amino acid that is chemically distinct from serine and cysteine by a single atom (Se instead of O or S, re-
spectively). Sec is incorporated into selenoproteins at an in-frame UGA codon specified by an mRNA stem-loop structure 
called the selenocysteine incorporating sequence (SECIS) presented in selenoprotein mRNA and specific selenocysteine 
synthesis and incorporation machinery. Selenoproteins are presented in all domains but are not found in all organisms. Al-
though several functions have been attributed to this class, the majority of the proteins are involved in oxidative stress de-
fense. Here, we discuss the kinetoplastid selenocysteine pathway and how selenium supplementation is able to alter the in-
fection course of trypanosomatids in detail. These organisms possess the canonical elements required for selenoprotein 
production such as phosphoseryl tRNA kinase (PSTK), selenocysteine synthase (SepSecS), selenophosphase synthase 
(SelD or SPS), and elongation factor EFSec (SelB), whereas other important factors presented in mammal cells, such as 
SECIS binding protein 2 (SBP) and SecP 43, are absent. The selenoproteome of trypanosomatids is small, as is the sele-
noproteome of others parasites, which is in contrast to the large number of selenoproteins found in bacteria, aquatic organ-
isms and higher eukaryotes. Trypanosoma and Leishmania are sensitive to auranofin, a potent selenoprotein inhibitor; 
however, the probable drug mechanism is not related to selenoproteins in kinetoplastids. Selenium supplementation de-
creases the parasitemia of various Trypanosome infections and reduces important parameters associated with diseases 
such as anemia and parasite-induced organ damage. New experiments are necessary to determine how selenium acts, but 
evidence suggests that immune response modulation and increased host defense against oxidative stress contribute to con-
trol of the parasite infection. 
Keywords: Auranofin, Leishmania sp, selenocysteine, selenoproteins, Trypanosoma cruzi, Trypanosoma evansi, Trypanosoma 
musculi. 
INTRODUCTION 
Biological trace elements are chemical elements that are 
required by an organism in minute quantities but that are 
toxic at higher levels. They include chromium, cobalt, cop-
per, iodine, iron, manganese, molybdenum, nickel, tungsten, 
vanadium, zinc, selenium and probably several others. These 
trace elements function as essential components of enzymes, 
in which they directly interact with substrates and facilitate 
the conversion to the product, donate or accept electrons in 
reduction and oxidation reactions, structurally stabilize bio-
logical molecules, or facilitate the binding of molecules to 
receptor sites on cell membranes [1]. Among these elements, 
selenium (Se), the major metalloid micronutrient, occurs 
naturally in foods but almost exclusively in organic com-
pounds. The primary forms of Se are selenomethionine, Se-
methylselenomethionine, selenocystine and selenocysteine 
[2]. Selenocysteine (Sec - U), the 21
st
 naturally occurring 
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amino acid, is co-translationally incorporated into selenopro-
teins encoded by an in-frame UGA codon.  
The human selenoproteome includes 25 selenoproteins 
containing at least one selenocysteine. Selenoproteins are 
essential for mammals, as demonstrated by the induction of 
early embryonic lethality in mice upon deletion of the sele-
nocysteine tRNA gene, which controls the expression of the 
entire selenoproteome. Although the function of most sele-
noproteins remains unknown, the few that have been charac-
terized are oxidoreductases in which the selenocysteine resi-
due is part of the catalytic core, rendering it more nucleo-
philic than a cysteine thiol in reactions at physiological pH. 
Thus, selenocysteine is more readily oxidized than cysteine 
and has the potential to repair oxidative damage to proteins 
by reducing tyrosyl radicals with higher efficiency [3].  
The selenocysteine synthesis pathway was first described 
in Leishmania in 2006 [4], and the existence of three seleno-
proteins in Kinetoplastida, two with mammalian homologs, 
SelK and SelT, and a third, SelTryp, exclusive to Kinetoplas-
tida were proposed later [5]. Auranofin, a selective inhibitor 
of selenoproteins, strongly inhibits the growth of Trypano-
soma brucei cultures [5], indicating the existence of a similar 
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pathway in that species. The identification of selenoprotein 
genes in Kinetoplastida and the characterization of the sele-
nocysteine synthesis and insertion pathways are also relevant 
from an evolutionary perspective because selenoproteomes 
have been identified in the three domains of life, but they are 
absent in fungi and plants [5]. This fact raises the question of 
what the selective pressure that maintained such a pathway 
in several organisms and was lacking in others could be. 
SELENOCYSTEINE BIOSYNTHESIS AND ITS SPE-
CIFIC INCORPORATION INTO SELENOPROTEINS 
Sec differs from cysteine by a single atom (Se versus S), 
conferring a lower pKa (5.2 versus 8.3) and higher reactivity. 
Certain selenoproteins that have a cysteine in place of Sec at 
their active sites exhibit up to 100-fold lower catalytic effi-
ciency, but evolutionary selection for this increased effi-
ciency has been counterbalanced by availability of Se, which 
has produced a complex distribution of Sec- and Cys-
containing homologs throughout nature [6]. 
During the translation of selenoproteins, cis- and trans-
acting factors work in concert to direct the translational ma-
chinery to insert Sec at UGA codons instead of terminating 
polypeptide synthesis. In eukaryotic cells, these factors in-
clude a specific mRNA secondary structure in cis with the 
selenoprotein gene, the Selenocysteine Insertion Sequence 
(SECIS), a Sec-specific tRNA (tRNA
[Ser]Sec
), a Sec synthase 
(SecS), and the tRNA modifying enzyme phosphoseryl-
tRNA[Ser]Sec kinase (PSTK). The translation process also 
requires SecP43, which methylates the 2-hydroxyl-ribosyl 
moiety in the Sec-tRNA
[Ser]Sec
 anticodon wobble position and 
may regulate the transport of the SecS-Sec tRNA
[Ser]Sec
 com-
plex between the nucleus and cytoplasm. A SECIS Binding 
Protein 2 (SBP2) and a specialized elongation factor (EFsec) 
are also involved in selenoproteins synthesis. Recently, other 
proteins have been shown to participate in the translation 
process, including the ribosomal protein L30, SECIS-
interacting nucleolin, and Sec-tRNA gene transcription-
activating factor (STAF) [6]. 
Sec synthesis invariably takes place on the tRNA
[Ser]Sec
, 
which is initially aminoacylated with serine by the seryl-
tRNASer synthetase (Fig. 1). The pathways then diverge in 
the different domains and recapitulate a trend seen with the 
decoding systems; i.e., eukaryotes rely on a more complex 
ensemble of factors. In bacteria, a pyridoxal phosphate 
(PLP)-dependent enzyme, selenocysteine synthase (SelA), 
uses selenophosphate (SeP) to directly convert Ser-
tRNA
[Ser]Sec
 into Sec-tRNA
[Ser]Sec 
(Fig. 1). In eukaryotes, Ser-
tRNA
[Ser]Sec
 is first phosphorylated by O-phospho-L-seryl 
(PSer)-tRNA
[Ser]Sec
 kinase to produce PSer-tRNA
[Ser]Sec
 (Fig. 
1). The phosphate apparently is required as a leaving group 
by the eukaryotic Sec synthase (SecS), which subsequently 
results in Sec-tRNA[Ser]Sec. In bacteria, SeP is synthesized 
by selenophosphate synthetase (SelD) from selenide. Eu-
karyotes harbor two homologs of SelD, selenophosphate 
synthetases 1 and 2 (SPS1 and SPS2), but only selenophos-
phate synthetase 2 (SPS2) participates in SeP synthesis [7] 
(Fig. 1). 
In eukaryotes, a secondary structure called the Selenocys-
teine Insertion Sequence (SECIS) is found in the 3 untrans-
lated region (3 UTR) of selenoprotein mRNA, whereas in 
bacteria this structure is positioned immediately after the 
selenocysteine UGA codon (Fig. 2). The presence of the 
SECIS element is necessary to direct message-specific sele-
nocysteine incorporation at UGA codons. SBP2 has been 
shown to bind to eukaryotic SECIS elements and to the ribo-
some, as well as to recruit EFsec, a specialized elongation 
factor that ultimately delivers the Sec-tRNA[Ser]Sec to the 
decoding center of the ribosome in mammals [8]. The bacte-
rial SECIS element is recognized by SelB [9], whereas in 
archaea [10] and kinetoplastids it is not known as the factor 
responsible for interaction (Fig. 2). 
 
Fig. (1). The selenocysteine synthesis pathways in Bacteria, Ar-
chaea, Eukaryota and trypanosomes are comparable. The SelA 
route is exclusive to Bacteria. The PSTK/SepSecS pathway is found 
in archaea and eukaryotes. Trypanosomes possess the same synthe-
sis machinery found in Archaea and Eukaryotes. 
The first suggestion that Kinetoplastidae have Sec syn-
thesis machinery originated from the identification of an 
RNA transcript in, named ODD1, of unknown function in 
Leishmania major cells which contains in-frame UGA stop 
codons and a putative SECIS element [4]. The identification 
of homologous genes encoding proteins involved in Sec syn-
thesis, such as SELD, SELB, and PSTK, in Leishmania and 
Trypanosoma genomes, as well as the two putative seleno-
protein genes (LmSel1, LinfSel1 of L. major and L. infantum 
respectively) strongly support the existence of a complete 
selenocysteine synthesis pathway in these organisms [11]. 
The eukaryotic SelB (higher eukaryotes), also called 
eSelB or eEFsec, does not bind the SECIS element in vitro. 
Instead, SECIS-binding protein 2 (SBP2) interacts with the 
SECIS element and stabilizes a SelB-SBP2-SECIS complex 
(Fig. 2). Furthermore, the ribosomal protein L30 has also 
been shown to bind eukaryotic SECIS elements and influ-
ence UGA recoding, which led to the proposal of a model for 
UGA decoding in eukaryotes. In archaea and trypanosomes, 
SECIS-binding proteins have not been identified. However, 
L30 homologs are encoded in many archaeal genomes. 
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Methanocaldococcus jannaschii, for example, encodes three 
proteins annotated as L30, and one was tested to determine 
whether it could function in eukaryotic selenoprotein synthe-
sis but failed [12, 13]. Trypanosomatid L30 homologs have 
been identified as well (T. brucei, Tb10.70.3160 or 
Tb10.70.3170; T. cruzi, Tc00.1047053503453.30, Leishma-
nia infantum, LinJ35.0340; Leishmania braziliensis, 
LbrM34_V2.0280), but the functional interaction of this pu-
tative L30 with the SECIS element has not been analyzed. 
Thus, how the UGA codon for Sec, the SECIS element and 
the translation complex (EFSec/ribosome) interact is estab-
lished in Archaea but in trypanosomatids it remains an unan-
swered question [14]. 
SPECIFIC CHARACTERISTICS OF KINETOPLAS-
TID SELENOCYSTEINE BIOSYNTHESIS MACHIN-
ERY 
Among the proteins involved in selenocysteine biosyn-
thesis and insertion machinery in Kinetoplastidae, the best 
characterized is the selenophosphate synthase (SPS). The 
insertion of selenium into Sec-dependent enzymes requires 
the formation of a highly reactive reduced selenium donor 
compound monoselenophosphate. Monoselenophosphate 
synthesis is catalyzed by SPS in a 1:1 ratio from selenide and 
ATP [5, 15-17]. 
SPS/SelD homologs can be divided into two major 
classes. Class I is characterized by the existence of a cysteine 
or selenocysteine residue in the active site and the catalysis 
of the selenide-dependent formation of monoselenophos-
phate. Replacement of the selenocysteine residue by cysteine 
decreased, but did not abolish, enzyme activity, whereas 
exchange of the Cys17 residue of the Escherichia coli en-
zyme with serine destroyed the catalytic activity. Class II, 
although they share a high level of sequence similarity with 
class I SPS/SelD, lacks the active-site cysteine or selenocys-
teine residue in position 17. Sequence alignment and recom-
binant SPS enzyme assays identified the kinetoplastid SPS as 
belonging to Class I [16]. 
The identification of a conserved cysteine residue at the 
N-terminal glycine-rich region of SelD/SPS (Cys-17 in E. 
coli, Cys-46 in L. major and Cys-42 in T. brucei) and a sele-
nocysteine (U) at the equivalent sequence position to mam-
malian SPS2 [18] led to the conclusion that this residue is 
involved in catalysis. This hypothesis was tested by generat-
ing the recombinant SPS mutants C46A and C42A in the L. 
major and T. brucei SPS enzymes, respectively, with a con-
sequent loss of activity tested either by functional comple-
mentation in E. coli or direct enzyme assay [16]. RNAi-
mediated ablation of the T. brucei SPS mRNA severely im-
pairs selenoprotein synthesis, indicating that SPS is catalyti-
cally active in trypanosomes. Surprisingly, no phenotypic or 
growth defects were observed in those cells [15]. Similar 
results showed that the absence of Sep-tRNA:Sec-tRNA 
synthase (SepSecS), another key enzyme in selenocysteine 
synthesis, does not affect the growth of the bloodstream form 
of T. brucei [19]. Those results suggested that selenoproteins 
are dispensable for T. brucei metabolism. Costa et al. (2011) 
[17] demonstrated that under stress conditions T. brucei cells 
lacking SPS presented growth deficiency in both the procyc-
 
Fig. (2). Sec incorporation pathway in Bacteria, Archaea, trypanosomes and other Eukaryotes (including mammals) comparing the known 
mediators of the interaction between Sec-tRNA, the SECIS element and the ribosome. 
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lic and bloodstream forms [17], indicating that selenopro-
teins are relevant for stress protection of the parasite cell, a 
condition it encounters during its life cycle, and therefore 
may even be a relevant drug target. 
Sec decoding employs a selenocysteyl-tRNA[Ser]Sec-
specific elongation factor in both prokaryotes (SELB or EF-
sec) and eukaryotes (eEFSec). The prokaryotic factor is a 
GTP-dependent RNA-binding protein consisting of an N-
terminal elongation factor domain specific to selenocysteyl-
tRNA
[Ser]Sec
 and a C-terminal SECIS-binding domain. EFsec 
delivers selenocysteyl-tRNA
[Ser]Sec
 to the ribosomal A site for 
Sec incorporation into the nascent protein, then dissociates 
from the ribosome and the SECIS element and reassembles 
with selenocysteyl-tRNA
[Ser]Sec
 for the subsequent round of 
Sec incorporation. In silico analysis of eukaryotic genomes 
resulted in the identification of the murine Sec elongation 
factor eEFSec. Like its prokaryotic counterpart, eEFsec 
binds to selenocysteyl-tRNA
[Ser]Sec
; however, it does not in-
teract directly with the SECIS elements. Instead, eEFsec 
interacts with SBP2 in the presence of selenocysteyl-
tRNA[Ser]Sec, thereby forming the Sec-decoding apparatus 
[20]. In trypanosomatids, EFSec was identified in 2006 [11], 
and genome searches did not reveal the presence of SBP2 in 
contrast to other eukaryotes. Moreover, the trypanosomatid 
EFSec has no identifiable SECIS-binding sequence at its C-
terminal domain as the E. coli SelB does. Therefore, re-
cently, it was not known whether the interaction between 
EFSec and the SECIS element occurs directly or if there is 
an unknown factor responsible for this interaction. 
The process of Sec incorporation into selenoproteins dif-
fers from bacteria to archaea and eukarya, although not all 
species within these domains have the capacity for seleno-
protein synthesis. However, in all organisms that have the 
selenocysteine pathway, Sec is formed through a tRNA-
dependent conversion of serine bound to tRNA
Sec
 by seryl-
tRNA synthetase. From this stage onward, the pathways di-
verge. In archaea and eukaryotes, including trypanosomatids, 
a two-step route is used, whereas in bacteria, a single step is 
sufficient for selenocysteine synthesis. The underlying rea-
son for this difference is an intriguing and open question. In 
archaea and eukaryotes, the essential enzyme PSTK, the first 
kinase described that to acts on a tRNA substrate, phos-
phorylates Ser-tRNA[Sec] to Sep-tRNA[Sec], which is then 
converted to Sec-tRNA[Sec] by Sep-tRNA:Sec-tRNA syn-
thase (SepSecS). Biochemical analyses have characterized 
the kinase- domain active site, and a phylogenetic recon-
struction shows that PSTK and SepSecS have co-evolved 
since the archaeal-eukaryotic divide. The identification of 
PSTK and SepSecS in Kinetoplastidae, associated with the 
absence of SELA, demonstrates that these organisms use 
only the two-step route for the selenocysteine biosynthesis 
and insertion [9]. SELA is a homodecamer of approximately 
500 kDa exclusive of to the bacteria domain, which it con-
verts seryl-tRNAsec (Ser-tRNAsec) into selenocysteyl-
tRNAsec (Sec-tRNAsec) in a pyridoxal-5´-phosphate (PLP)- 
dependent mechanism [5, 6, 21]. The T. brucei PSTK and 
SepSecS knock-out (KO) cell lines show that the three sele-
noproteins are absent. Moreover, tetracycline-inducible ec-
topic expression of T. brucei SepSecS in the T. brucei Sep-
SecS KO cell line restored 
75
Se labeling of all 3 selenopro-
teins. These experiments show that both T. brucei PSTK and 
SepSecS are indispensable for selenoprotein synthesis [15]. 
Kinetoplastida tRNA[Sec] presents common features ob-
served in other known tRNA
Sec
, but it has its own peculiari-
ties. The anticodon UCA, required for the recognition of the 
UGA codon, the predicted folding of tRNA
Sec
 revealed the 
characteristic long variable loop arm consisting of a six base-
pair long stem and the presence of a usual pseudopyrimidine 
site [11]. Another important feature observed in T. brucei 
tRNA
Sec
 is the long D-loop with seven base pairs, contrasting 
with the tRNA
Ser
 short D-loop of three to four base pairs. 
The length and secondary structure of the D-loop, but not its 
sequence composition, are the major components by which 
archaea and human PSTKs discriminate between tRNA
Sec
 
and tRNA
Ser
 [22]. A mutated human tRNA
Sec
 with a four-
base-pair D-loop showed decreased PSTK phosphorylation 
when compared with the wild type with a six-base-pair D-
loop [22], and recent data demonstrated that identification of 
tRNA
Sec
 in archaea is dependent on the D-loop structure 
[23]. Moreover, the Kinetoplastidae tRNA
Sec
 has a 7/5 struc-
ture in the acceptor-TC stem, with seven nucleotides in the 
acceptor stem and five nucleotides in the TC stem, while 
the human [24] and the archaea [25] tRNA
Sec
 have a 9/4 
structure. These structural differences in the tRNA
Sec
 of Ki-
netoplastidae suggest an equivalent adaptive modification in 
the enzymes that interact with and recognize such tRNAs, 
including the ribosome A site. 
SELENOCYSTEINE AND SELENOPROTEINS 
Although selenoproteins are present in all three domains, 
only approximately 20% of the completed bacterial and 14% 
of completed archaeal genomes contain the pathway. In addi-
tion, the number of selenoproteins in a genome varies from 
one to more than ten, with Carboxydothermus hydrogeno-
formans, Eubacterium acidaminophilum, Geobacter metal-
lireducens, Geobacter sulfurreducens and M. Jannaschii 
having the largest number of selenoproteins among the par-
tially and completely sequenced genomes. Analysis of the 
composition of selenoproteomes revealed that most seleno-
proteins are involved in redox mechanisms, which use Sec 
either to coordinate a redox-active metal (molybdenum, 
nickel or tungsten) or in Sec: thiol redox catalysis. The pres-
ence of selenoproteins that were found in a small number of 
genomes (mostly homologs of thiol-dependent oxidoreduc-
tases) contrasted with the broad occurrence of their Cys 
homologues. This observation indicates that these selenopro-
teins evolved recently, probably from Cys-containing pro-
teins. Conversely, formate dehydrogenases, which were pre-
sent in most genomes as selenoproteins, appear to be of an-
cient origin. Thus, both a lineage-specific expansion (recent 
origin) and the presence of core selenoproteins (ancient ori-
gin) contribute to the composition of selenoproteomes [26].  
The size of the selenoproteome varies dramatically among 
eukaryotes. The highest number of selenoproteins is observed 
in aquatic organisms, whether they are animals (e.g., fish) or 
plants (e.g., algae). Some algae are especially rich in seleno-
proteins. Blue-green algae are thought to be among the first 
photosynthetic organisms, and it has been hypothesized that 
the antioxidant function offered by selenoproteins is required 
to protect cells from oxidation. The availability of steady sup-
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plies of Se in seawater could have made it possible for aquatic 
organisms to more easily increase their use of this element in 
various oxidoreductases [27]. 
Similar to other eukaryotic parasites, the selenoproteo-
mes of Leishmania and Trypanosoma are small. Three sele-
noproteins were proposed in Kinetoplastida, two of which 
are homologs of SelK and SelT, and the third is a novel sele-
noprotein with two rhodanese domains and one rubredoxin 
oxygen oxidoreductase domain that appears to be a Kineto-
plastida-specific selenoprotein [5, 27]. None of the functions 
of these selenoproteins are known, although new data sug-
gest their participation in redox processes [17]. 
Selenoproteins have been subdivided into three groups 
based upon the location of the selenocysteine. The first and 
most abundant group includes proteins in which the seleno-
cysteine residue is located in the N-terminal portion of a 
relatively short functional domain followed by an alpha he-
lix. The second group of eukaryotic selenoproteins is charac-
terized by the presence of Sec in the C-terminal sequence. 
The third group is Sec coordinators with metal ions in the 
active site, such as Mo, W and Ni and includes hydro-
genases, formate dehydrogenases and formylmethanofuran 
dehydrogenases exclusive of prokaryotes [28]. 
The selenoproteomes of flagellated protozoa contain 
three selenoproteins. These include the distant homologs of 
mammalian SelK and SelT and a novel multidomain seleno-
protein designated SelTryp. In SelK and SelTryp, Sec is at 
the C-terminus, and in all three selenoproteins, it is found 
within predicted redox motifs. SelTryp has neither Sec- nor 
cysteine-containing homologs and appears to be a Kineto-
plastida-specific protein [5]. 
Selenoprotein T (SelT) is expressed from the embryonic 
stage to adulthood in rats and is located in the endoplasmic 
reticulum. It belongs to a group of selenoproteins that in-
cludes SelW, SelH and SelV with sequence similarity to pro-
teins containing a thioredoxin-like domain and a conserved 
Cys-X-X-Sec motif. SelT function may be related to stress 
defense and calcium mobilization [6]. 
Selenoprotein K (Selk) is a small protein (16 kDa) lo-
cated in the membrane of the endoplasmic reticulum, al-
though there is evidence of its association with the cell 
plasma membrane. Northern blot analysis suggests high Selk 
expression in the human heart. In mice, SelK specific mRNA 
was detected in different locations, with particular accumula-
tion in the spleen [6].  
In SelTryp, the Sec residue is encoded in the C-terminal 
region within the conserved sequence SI(V)I(V)CI(V)SUPR 
that comprises the conserved CXXU motif. It has been pro-
posed that SelTryp is involved in redox processes. Although 
Sec in selenoproteins is frequently found in loops between 
secondary structures, the C-terminal location occurs in other 
eukaryotic selenoproteins, such as thioredoxin, Selk, SelS 
and SelO [5, 6], so the location of Sec in the Kinetoplastidae 
Selk and SelTryp is common to other known selenoproteins. 
THE GOLD COMPOUND ACTIVITY IN PROTO-
ZOAN PARASITES 
Although they are often considered unselective, a few 
studies show promising results of the activity of metals 
against parasites. Compounds containing zinc, platinum and 
gold inhibit growth and metabolically important enzyme 
activities of protozoan parasites.  
Gold-containing compounds have been used in human 
therapy for centuries and have been described as having anti-
rheumatic, anti-cancer and anti-microbial activities. In 1935, 
studies showed that gold salts reduced inflammatory reac-
tions, especially those related to arthritis. In 1985, the com-
pound auranofin (Ridaura SKF 39162-D) was shown to have 
significant efficacy in rheumatoid arthritis treatment [29, 30]. 
Although widely used, the mechanism of action of auranofin 
(AF) remains controversial. Like AF, other gold complexes, 
such as aurothiomalate and aurothioglucose (Fig. 3), have 
been shown to have an antiparasitic activity against Plasmo-
dium sp., Ancylostoma sp., Leishmania sp., and Schistosoma 
sp. [31-35]. The structures of these gold-containing drugs are 
presented in (Fig. 3). 
 
Fig. (3). Chemical structures of gold(I) thiolates used in the treat-
ment of rheumatoid arthritis and tested as inhibitors of selenocys-
teine synthesis. Aurothioglucose (solganol); aurothiomalate (myoc-
risin) and triethylphosphinegold(I) tetraacetatothioglucose (au-
ranofin). 
Navarro et al. (2007) [36] showed that a gold complex 
synthesized by the reaction of HAuCl4 with dipyrido-
phenazine has anti-proliferative activity against L. mexicana 
and suggested that the activity could be associated with the 
interaction between the gold complex with the parasite DNA. 
Lobanov and co-workers (2006) [5] demonstrated the effect 
of auranofin (AF) (Fig. 3), a specific inhibitor of selenopro-
teins, in T. brucei brucei cells. In various organisms, seleno-
proteins have oxidoreductase functions, preventing or repair-
ing damage to cellular components, in addition to the regular 
redox reactions. AF showed high inhibition of these proteins, 
which are essential to parasite survival, reducing T. cruzi 
viability in vitro and in vivo [5]. Thioredoxin reductase inhi-
bition by AF is also associated with important modifications 
of the intracellular redox balance, leading to severe oxidative 
stress, as observed in Plasmodium falciparum and Schisto-
soma mansoni cells in vitro [30, 37, 38]. However, Ilari et al. 
(2012) [32] showed that AF strongly inhibited trypanothione 
reductase (TR), a non-selenocysteine enzyme. The structural 
analysis of reduced L. infantum TR in complex with NADPH 
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and AF demonstrated that the inhibitory mechanism is simi-
lar to that of Sb(III). In fact, upon TR reduction by NADPH, 
Au(I) binds to the cysteine residues involved in the catalytic 
triad (Cys52, Cys57 and His461) with a planar triangular 
coordination involving a chloride ion, while two Sb(III) and 
Ag bind the three residues of the catalytic triad of the re-
duced enzyme [35]. 
AF and other gold-containing compounds are strong in-
hibitors of protozoan thioredoxin glutathione reductase, cys-
teine proteases and trypanothione reductase, which are key 
enzymes of the parasite metabolism. The data has shown that 
AF interaction with selenoproteins, also key enzymes in the 
parasite oxidative stress response, indicating that further in-
vestigation of these compounds as potential lead compounds 
could lead to the development of a novel chemotherapy 
strategy to treat Trypanosoma parasite infections. 
Recent studies indicate that these drugs directly interfere 
in immune system function, acting as an effective inhibitor 
of proteases, mainly cysteine proteases, which are factors 
that are involved in the progression of rheumatoid arthritis, 
and new applications of auranofin in the treatment of various 
diseases are described, including several types of leukaemia, 
carcinomas, and parasitic, bacterial, and viral infections [39].  
EFFECTS OF SELENIUM SUPPLEMENTATION ON 
TRYPANOSOMIASIS 
Selenoproteins have multiple biological activities, such 
as redox signaling, antioxidant defense and immune re-
sponse, and individual selenoproteins exhibit tissue specific-
ity in their expression levels and regulation patterns. Interest-
ingly, the most highly expressed selenoprotein mRNA in 
macrophages was GPx1 (glutathione peroxidase), which has 
antioxidant activity [40]. 
Various articles have described immune system modula-
tion by selenium, with beneficial effects against different 
infections. The humoral response was affected by selenium 
deficiency; for example, IgM, IgG and IgA titers decreased 
in rats, and IgM and IgG titers decreased in humans. Sele-
nium deficiency does not affect neutrophil numbers in a 
range of species, but certain aspects of their function are 
defective. Neutrophils from selenium-deficient mice, rats 
and cattle are able to ingest pathogens in vitro but are less 
able to kill them than neutrophil-sufficient animals. These 
effects have been associated with decreased cytosolic GPx 
(mainly GPx1) activity in the neutrophils, which allows the 
free radicals that are produced through respiration to kill the 
neutrophil themselves [41, 42].  
Macrophages deficient in some selenoproteins have a 
normal inflammatory response, but this deficiency led to an 
alteration in the expression of matrix-related genes. Seleno-
protein-deficient macrophages also diminished migration in 
a protein gel matrix [43, 44]. In the macrophage cell line 
J774.1, in vitro selenium supplementation enhanced phago-
cytosis, degranulation and the production of superoxide after 
stimulation. The release of the cytokines TNF-, IL-1 and 
IL-6 was also enhanced in selenium-supplemented macro-
phages when compared to selenium-deficient cells [45]. Se-
lenium also has been linked to viral infection via enhanced 
T-cell function and a TNF--induced increase in natural kil-
ler cell activity.  
In different parasite infections, selenium deficiency alters 
various immune response components. For example, for 
Cryptosporidium parvum, the level of Th1 and Th2 cytoki-
nes released by proliferating T cells revealed different ex-
pression patterns in infected Se-adequate mice versus Se-
deficient mice. In selenium-adequate mice, the immune re-
sponse appeared to be dominated by both Th1 and Th2 cyto-
kines with an evident increase of IFN-, IL-2 and IL-4 dur-
ing the early stages of infection. The level of IFN- remained 
high until recovery from the infection in the Se-adequate 
mice. The low expression level of Th2 cytokines in deficient 
mice may have contributed to the severe C. parvum-induced 
enteritis that occurred within two or three weeks [46]. In 
Toxocara canis larvae infection, the number of worms was 
reduced, but the migratory route was not affected by sele-
nium supplementation. IL-5 expression, eosinophil response 
and IL-6 production were enhanced in mice infected with T. 
canis that received a sodium selenite supplement [47]. In 
other cases, selenium deficiency impaired the innate immune 
response against Listera monocytogenes (Selenium defi-
ciency impairs host innate immune response and induces 
susceptibility to Listeria monocytogenes infection.) and in-
creased mortality with a marked reduction in body weight 
and reduction of levels of TNF- and INF- in mice infected 
with the H1N1 influenza virus [48].  
Studies with selenium supplementation in trypanosomia-
sis demonstrated, in most cases, a decrease in parasitemia 
and improvement in symptoms of this disease such as reduc-
tion of anemia and organ damage. However, the immu-
nological mechanisms involved in the selenium benefits have 
been poorly explored. The parameters discussed above could 
explain the reduction in the infection, such as macrophage 
stimulation and increase of antibody titers. The paragraphs 
below described how the selenium supplementation affects 
the course of trypanosomiasis and details potential disease 
modifications.  
A study of advanced chronic chagasic patients reported 
that low Se levels were positively correlated with cardiac 
insufficiency [49]. Experiments designed to investigate the 
role of Se demonstrated an increased susceptibility to infec-
tion in mice with a Se-deficient diet, and an increased sever-
ity of myopathy was observed in chronically infected mice 
with Se-depleted diets. Se supplementation alleviated heart 
muscle damage and has previously been shown to reduce 
parasitemia and mortality in infected mice. Se supplementa-
tion beginning two weeks before mice were infected with T. 
cruzi prevented the extreme dilation of the right ventricle, 
which is routinely observed in chronically infected mice, 
whereas Se supplementation of uninfected mice had no ef-
fect on cardiac dimensions. Similar supplementation also 
reduced intestinal dilation and preserved intestinal motility 
[49]. Recently, accumulation of selenium in the heart of 
animals infected with T. cruzi was reported, and these data 
suggest that some minerals caused modifications of cardiac 
tissue in response to the parasite. However, the biological 
implications of these findings have not been explored yet 
[50].  
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Selenium supplementation in rats infected with Trypano-
soma brucei significantly reduced parasitemia in animals 
treated with 4 and 8 ppm of sodium selenite, whereas diets 
supplemented with 16 ppm increased parasitemia. This effect 
can be attributed to selenium toxicity for the host. Supple-
mentation with selenium improved the packed cell volume 
and hemoglobin concentration, parameters that indicated a 
reduction in anemia, a common feature in Sleeping Sickness. 
This may be due to the relatively lower parasitemia recorded 
in the supplemented group because the degree anemia has 
been positively correlated with the level of parasitemia [51].  
Selenium supplementation associated with treatment with 
diminazene aceturate reduces parasitemia and increases the 
survival of Trypanosoma evansi-infected mice. The study 
demonstrated that this reduction occurred independent of 
supplementation of vitamin E. After 30 days, selenite sup-
plementation did not change the hematocrit or total leuco-
cytes, monocytes and eosinophils. However, 60 days post 
infection, a significant hematocrit reduction was found in the 
groups that did not receive sodium selenite [52]. Once again, 
as described for the T. brucei infection, selenium supplemen-
tation prevented anemia, although the causes of these effects 
are not completely understood.  
Knockdown experiments demonstrated that selenopro-
teins are not required for cell viability for the procyclic and 
bloodstream forms of Trypanosoma brucei [15, 19] in nor-
mal culture conditions. Other data showed that T. brucei 
cells with a silenced SPS2 gene exhibited growth deficiency 
under oxidative stress conditions caused by overgrowth or 
the presence of H2O2 in the medium, suggesting that seleno-
proteins are required only under specific conditions, such as 
during oxidative stress [17]. Eze et al. [51] and Tonin et al. 
[52] suggested that the mechanism by which Se reduces T. 
evansi and T. brucei parasitemia may be attributed to the 
antioxidant function of enzymes such as glutathione peroxi-
dase or other proteins that contain selenocysteine, which is 
involved in host oxidative stress defense. The association 
between selenocysteine and oxidative stress has already been 
demonstrated. The most important side effect of statins, a 
class of therapeutics used to control cholesterol, is myotoxic-
ity, which is responsible for the withdrawal of cerivastatin 
from market in 2001. These effects can be explained by the 
fact that statins impaired selenocysteine synthesis in muscle 
cells, indiscriminately affecting selenoprotein expression. 
Statin treatment weakens the antioxidative defense against 
different peroxides, and these pro-oxidative mechanisms are 
potentially connected to selenoprotein suppression [53]. 
Therefore, the selenium supplementation or selenoproteins 
contribute to oxidative stress defense in the parasite and host, 
and determining which conditions affect this balance is im-
perative. Some concentration of selenium could increase the 
immune response, whereas others cause the parasites to be-
come more resistant to clearance.  
Other important data demonstrated that selenium-
deficient mice infected with Trypanosoma musculi cleared 
the infection by 16 days post-inoculation (PI), whereas con-
trol mice sustained parasitemia until 24 days PI. Decreased 
severity of Salmonella Typhimurium infection in Se-
deficient rats was reported, and this response was suggested 
to be the result of competition between the host and parasite 
for the available Se [54]. Additionally, the ability of micro-
organisms to grow and replicate depends on the availability 
of the nutrients required for their development. Thus, a con-
tinuous Se-deficient diet created an environment unfavorable 
for the development of T. musculi [55].  
Epidemiological studies indicated that selenium levels in 
the serum are correlated with disease states. There was a 
positive relationship between selenium concentrations and 
GPx1 activities in patients with cutaneous leishmaniasis 
(CL), suggesting that selenium plays an important role in the 
pathophysiologic processes of CL. Selenium levels and the 
GPx activity of the CL patients were lower than those of the 
healthy controls. The decreasing levels of selenium may be a 
host defense mechanism against Leishmania infection [56, 
57]. 
Little is known about selenium metabolism itself in try-
panosome cells. It is not known whether Kinetoplastidae 
possess a selenium detoxification mechanism similar to other 
organisms such as mammals. In these cells, inorganic forms 
of selenium such as selenite and selenate are reduced to se-
lenide (H2Se) in reactions catalyzed by glutathione reduc-
tase. Methylation of selenide by methyltransferase, using S-
adenosylmethionine as the methyl donor, results in (CH3)2Se 
(dimethyl selenide) as the major product. Methylated Se 
compounds are the major forms in which selenium is ex-
creted in mammals. The volatile dimethyl selenide is lost in 
the lungs, and the soluble trimethylselenonium cation is ex-
creted in the urine [2]. In vitro tests showed trypanocidal 
effects associated with treatment with diminazene aceturate 
and sodium selenite against T. evansi. At elevated concentra-
tions, selenium is extremely toxic and may manifest when 
pro-oxidant conditions exceed cellular antioxidant defenses 
[58]. This hypothesis might explain the mechanism of dose-
dependent toxicity against T. evansi in vitro [52]. Trypano-
soma cruzi growth curves in medium with sodium selenite at 
10 to 50 mM showed a reduction in cell viability with a 
marked dose-dependent effect that corroborated the results 
found for T. evansi (unpublished data). However, the exact 
mechanism of selenium detoxification remains unclear in 
trypanosomatids. 
Growth curves of L. tarentolae in medium supplemented 
with high concentrations of selenium suggest that this mi-
cronutrient accelerates the growth of these cells [59]. It is 
possible that selenium is essential for kinetoplastid cell vi-
ability in multiple growth stages, not only during the station-
ary phase or under oxidative stress. However, further ex-
periments are needed to better understand the role of sele-
nium in trypanosomatids development. 
In sum, the data suggest that selenocysteine and seleno-
proteins are important for parasite defense, mainly against 
oxidative stress, and this pathway could be an important drug 
target. New experiments are necessary to establish the spe-
cific mechanisms of how selenium supplementation and se-
lenoproteins act in trypanosomatid infection. Treatment re-
duces parasitemia, anemia and organ damage; these observa-
tions probably are connected to the positive effects of sele-
nium on modulation of the immune system. 
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